BlackRock, Inc. 13D and 13G filings for Bio-Techne Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-16 7:02 pm Sale | 2025-06-30 | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 11,011,556 7.000% | -2,831,725 (-20.46%) | Filing |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 13,843,281 8.700% | 0 (Unchanged) | Filing |
| 2024-10-21 4:11 pm Sale | 2024-09-30 | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 13,843,281 8.700% | -4,290,631 (-23.66%) | Filing |
| 2024-01-24 09:46 am Purchase | 2023-12-31 | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 18,133,912 11.500% | 2,245,272 (+14.13%) | Filing |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 15,888,640 10.100% | 0 (Unchanged) | Filing |
| 2023-01-20 09:43 am Sale | 2022-12-31 | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 15,888,640 10.100% | -1,424,556 (-8.23%) | Filing |
| 2022-01-27 11:00 am Unchanged | 2021-12-31 | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 17,313,196 11.000% | 0 (Unchanged) | Filing |
| 2022-01-25 3:03 pm Sale | 2021-12-31 | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 17,313,196 11.000% | -78,916 (-0.45%) | Filing |